TS-1 enhances the effect of radiotherapy by suppressing radiation-induced hypoxia-inducible factor-1 activation and inducing endothelial cell apoptosis-Reference-Cited by-同舟云学术

TS-1 enhances the effect of radiotherapy by suppressing radiation-induced hypoxia-inducible factor-1 activation and inducing endothelial cell apoptosis

Published:2008-09-23 Issue:11 Volume:99 Page:2327-2335
ISSN:1347-9032
Container-title:Cancer Science
language:en
Short-container-title:

Author:

Zeng Lihua,Ou Guangfei,Itasaka Satoshi,Harada Hiroshi,Xie Xuejun,Shibuya Keiko,Kizaka-Kondoh Shinae,Morinibu Akiyo,Shinomiya Kazumi,Hiraoka Masahiro

Publisher

Wiley

Subject

Cancer Research,Oncology,General Medicine

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1349-7006.2008.00943.x/fullpdf

Reference35 articles.

1. Biological Basis of Combined Radio- and Chemotherapy

2. The histological structure of some human lung cancers and the possible implications for radiotherapy;Thomlinson;Br J Cancer,1955

3. The concentration of oxygen dissolved in tissues at the time of irradiation as a factor in radiotherapy;Gray;Br J Radiol,1953

4. Blood flow, oxygen and nutrient supply, and metabolic microenvironment of human tumors: a review;Vaupel;Cancer Res,1989

5. Exploiting tumour hypoxia in cancer treatment;Brown;Nat Rev Cancer,2004

Cited by 48 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Definitive S-1/mitomycin-C chemoradiotherapy for stage II/III anal canal squamous cell carcinoma: a phase I/II dose-finding and single-arm confirmatory study (JCOG0903);International Journal of Clinical Oncology;2023-06-07

2. Short- and Long-term Outcomes of Chemoradiotherapy for Squamous Cell Carcinoma of the Anal Canal in 17 Patients;Nippon Daicho Komonbyo Gakkai Zasshi;2022

3. Correlation between the number of viable tumor cells and immune cells in the tumor microenvironment in non‐small cell lung cancer after induction therapy;Pathology International;2021-06-11

4. Early glottic cancer treatment with concurrent chemoradiotherapy with once-daily orally administered S-1;NAGOYA J MED SCI;2021

5. The State-of-the-Art of Phase II/III Clinical Trials for Targeted Pancreatic Cancer Therapies;Journal of Clinical Medicine;2021-02-03